Xarelto Lawsuit Update: Lawsuits Make Common Allegations Against Xarelto Manufacturers

October 29, 2015 – – BloodThinnerHelp.com reports today on the legal basis for the Xarelto lawsuits filed in the multidistrict litigation. These lawsuits were able to be consolidated into an MDL in the United States District Court for the Eastern District of Louisiana because they all made similar allegations against the same defendants, the manufacturers of Xarelto, Bayer AG and Janssen Pharmaceuticals, a subdivision of Johnson&Johnson. The specific allegations that all of these lawsuits make are listed below:

-Xarelto manufacturers failed to warn about the risks of Xarelto, specifically the irreversible uncontrollable bleeding that may occur in some patients

-Xarelto contained a design defect in that it did not safely provide an anti coagulation solution, but instead posed greater risks to patients of internal bleeding due to no reversal agent

-Xarelto fraudulently concealed knowledge of irreversible life threatening events and how doctors should intervene and stabilize patients

-Xarelto manufacturers were negligent in placing the drug into the marketing knowing there was no antidote

-Xarelto manufacturers made a negligent misrepresentation in marketing Xarelto as a safe blood thinner

-Xarelto did not provide benefits greater than products that already existed in the marketplace in a safer manner such as Warfarin

For more detailed information and updates on the Xarelto litigation, click here.

The Xarelto MDL:

Consolidating these lawsuits into an MDL is generally a good move for all parties involved. An MDL is very different from a class action lawsuit even though these terms get confused quite often. In an MDL, each case is still tried as an individual case. This is very appropriate for the Xarelto trials because the injuries and damages vary dramatically from plaintiff to plaintiff. Consolidating cases into an MDL also saves on judicial resources and expedites the entire judicial process for both parties. The pre-trial and discovery stages are streamlined and the MDL allows resources and paperwork to move much more quickly through the judicial system.

The Xarelto MDL is consolidated in the United States District Court for the Eastern District of Louisiana and is presided over by United States District Judge Eldon Fallon. The MDL is still in the pretrial stages and we are quite a while away from any resolution, but recently an important step forward was taken. The dates for the first trials of the MDL were set. These trials are called the bellwether trials and there are currently four of them scheduled throughout early to mid-2017.

For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60004932